Essential Partners’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.45K Sell
181
-50
-22% -$374 ﹤0.01% 2042
2026
Q2
$1.6K Sell
231
-164
-42% -$968 ﹤0.01% 2062
2026
Q1
$1.62K Buy
+395
New +$1.91K ﹤0.01% 2083

Other funds holding EOLS

Essential Partners's EOLS Position: Q3 2026 in Review

Essential Partners reduced its Evolus (EOLS) stake by 22% in Q3 2026, selling an estimated $374 and leaving 181 shares worth $1.45K. The position accounts for ﹤0.01% of the portfolio, ranked #2042.

Essential Partners first reported a position in EOLS in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.62K in Q1 2026. 15 funds tracked by Wall St. Rank hold EOLS as of Q3 2026.

  • Essential Partners held 181 shares of Evolus worth $1.45K as of Q3 2026.
  • Essential Partners sold 50 Evolus shares in Q3 2026, an estimated $374.
  • Evolus made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2042 holding.
  • Essential Partners first reported a position in Evolus in Q1 2026 and has held it in 3 quarters since.
  • Essential Partners's Evolus position peaked at $1.62K in Q1 2026.
  • 15 funds tracked by Wall St. Rank held Evolus as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.